tirzepatide free trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide for Obesity Treatment and

Factors to consider when switching There are several factors to consider when switching from Ozempic to Zepbound, including the following: Weight loss goals Ozempic is approved by the FDA for type 2 diabetes management and Zepbound has been approved for weight loss

An online consult or a telehealth visit consult first or we can do an in person consult as well with that consult

Segment Insights Product Type Insights The injectables segment dominated the market with the largest share in 2025

If this happens, eat something containing sugar, such as dextrose tablets, sweets/candies or a sugary drink (non-diet), and then follow this up with a snack such as a sandwich or a piece of fruit